Both the Chinese government and investors see tremendous opportunities ahead for private healthcare in China, as only 10% of the country’s medical services are...
Oncology has become the biggest therapy class in terms of revenue. IQVIA, a global provider of analytics, technology solutions, and contract research services to...
In 2017, the Chinese government pledged to provide better healthcare services with respect to accessibility and affordability to the majority of the nation's almost...
The worldwide oncology drug market, including therapeutic and supportive care, reached $133 billion in 2017, representing an increase of almost 40% from...
Many pharmaceutical companies have been generating most of their revenue from developing oncology treatments, as cancer is among the leading causes of death. Five of the top-15 bestselling drugs worldwide are for oncology. The global…
The pace of rising incidence of cancer globally is alarming, especially in emerging countries. According to the European Society for Medical Oncology (ESMO), the...
China’s healthcare industry continues to expand at an amazing pace, as the related spending is projected to reach $2.3 trillion by 2030. The promising outlook...
The Future of China’s Private Healthcare